Don’t miss the latest developments in business and finance.

Home / Author / Saket Misra
Saket Misra

Saket Misra

Saket Misra

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Updated On: 18 Oct 2023 | 1:05 PM IST

Test set preference1

testing

Updated On: 16 Oct 2023 | 1:29 PM IST